MULTIDRUG RESISTANCE ACTIVITY IN HUMAN-LYMPHOCYTES

被引:92
作者
COON, JS
WANG, YZ
BINES, SD
MARKHAM, PN
CHONG, ASF
GEBEL, HM
机构
[1] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT IMMUNOL,1653 W CONGRESS PKWY, CHICAGO, IL 60612 USA
[2] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT IMMUNOL MICROBIOL, CHICAGO, IL 60612 USA
[3] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT PATHOL, CHICAGO, IL 60612 USA
[4] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT GEN SURG, CHICAGO, IL 60612 USA
关键词
D O I
10.1016/0198-8859(91)90110-U
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The multidrug resistance gene (mdr1) is a member of the recently described ATP binding cassette (ABC) superfamily of transporters. Family members include: (1) the cystic fibrosis transmembrane conductance regulator gene; (2) the hlyB gene of bacteria, and (3) the histocompatibility antigen modifier (HAM) gene. The level of expression of mdr1 correlates with multidrug resistance (MDR), the ability of cells to efflux otherwise toxic doses of several chemotherapeutic agents. MDR activity is also associated with the efflux of cationic lipophilic compounds such as the fluorescent dye rhodamine 123. Recently it was reported that normal lymphocytes efflux rhodamine 123, suggesting that these cells possess MDR-like activity due to the expression of mdr1. In this study, using two-color flow cytometric analysis, we observed that the ability to efflux rhodamine 123 was heterogeneous among human lymphocyte subsets in the order of CD8 > CD4 > CD20. Rhodamine 123 efflux and accumulation in lymphocytes was sensitive to the known MDR reversing agents, verapamil and Solutol HS 15. Collectively, these data suggest that an MDR-like transport system is present in normal lymphocytes and may be important for trafficking of molecules involved in lymphocyte function.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 31 条
[1]   ISOLATION AND GENETIC-CHARACTERIZATION OF HUMAN KB-CELL LINES RESISTANT TO MULTIPLE-DRUGS [J].
AKIYAMA, SI ;
FOJO, A ;
HANOVER, JA ;
PASTAN, I ;
GOTTESMAN, MM .
SOMATIC CELL AND MOLECULAR GENETICS, 1985, 11 (02) :117-126
[2]   MECHANISM OF MULTIDRUG RESISTANCE [J].
BRADLEY, G ;
JURANKA, PF ;
LING, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) :87-128
[3]   THE FLOW CYTOMETRIC CROSSMATCH - DUAL-COLOR ANALYSIS OF T-CELL AND B-CELL REACTIVITIES [J].
BRAY, RA ;
LEBECK, LK ;
GEBEL, HM .
TRANSPLANTATION, 1989, 48 (05) :834-840
[4]   STRUCTURE AND EXPRESSION OF THE HUMAN MDR (P-GLYCOPROTEIN) GENE FAMILY [J].
CHIN, JE ;
SOFFIR, R ;
NOONAN, KE ;
CHOI, K ;
RONINSON, IB .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (09) :3808-3820
[5]   AN ALTERED PATTERN OF CROSS-RESISTANCE IN MULTIDRUG-RESISTANT HUMAN-CELLS RESULTS FROM SPONTANEOUS MUTATIONS IN THE MDR1 (P-GLYCOPROTEIN) GENE [J].
CHOI, K ;
CHEN, C ;
KRIEGLER, M ;
RONINSON, IB .
CELL, 1988, 53 (04) :519-529
[6]  
COON JS, 1991, CANCER RES, V51, P897
[7]   MULTIDRUG-RESISTANCE GENE (P-GLYCOPROTEIN) IS EXPRESSED BY ENDOTHELIAL-CELLS AT BLOOD-BRAIN BARRIER SITES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
CASALS, D ;
RITTMANGRAUER, L ;
BIEDLER, JL ;
MELAMED, MR ;
BERTINO, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (02) :695-698
[8]   THE 3 MOUSE MULTIDRUG RESISTANCE (MDR) GENES ARE EXPRESSED IN A TISSUE-SPECIFIC MANNER IN NORMAL MOUSE-TISSUES [J].
CROOP, JM ;
RAYMOND, M ;
HABER, D ;
DEVAULT, A ;
ARCECI, RJ ;
GROS, P ;
HOUSMAN, DE .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (03) :1346-1350
[9]  
DARZYNKIEWICZ Z, 1982, CANCER RES, V42, P799
[10]   MHC CLASS-II REGION ENCODING PROTEINS RELATED TO THE MULTIDRUG RESISTANCE FAMILY OF TRANSMEMBRANE TRANSPORTERS [J].
DEVERSON, EV ;
GOW, IR ;
COADWELL, WJ ;
MONACO, JJ ;
BUTCHER, GW ;
HOWARD, JC .
NATURE, 1990, 348 (6303) :738-741